American National Bank & Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,530
Closed -$1.05M 204
2018
Q3
$1.05M Sell
5,530
-1,190
-18% -$219K 0.3% 58
2018
Q2
$1.12M Sell
6,720
-12,816
-66% -$2.06M 0.32% 63
2018
Q1
$3.29M Buy
19,536
+1,357
+7% +$228K 0.94% 48
2017
Q4
$2.97M Sell
18,179
-818
-4% -$147K 0.84% 41
2017
Q3
$3.89M Buy
18,997
+115
+0.6% +$26.7K 1.17% 34
2017
Q2
$4.59M Buy
18,882
+3,649
+24% +$857K 1.47% 26
2017
Q1
$3.64M Buy
15,233
+95
+0.6% +$22.1K 1.13% 36
2016
Q4
$3.18M Sell
15,138
-186
-1% -$38.5K 1.04% 43
2016
Q3
$3.53M Buy
15,324
+530
+4% +$130K 1.18% 36
2016
Q2
$3.42M Buy
14,794
+40
+0.3% +$9.22K 1.25% 33
2016
Q1
$3.96M Buy
14,754
+5,280
+56% +$1.51M 1.49% 28
2015
Q4
$2.96M Buy
+9,474
New +$2.82M 1.15% 36
2015
Q2
Sell
-15,102
Closed -$4.5M 334
2015
Q1
$4.5M Buy
15,102
+614
+4% +$175K 1.74% 21
2014
Q4
$3.73M Sell
14,488
-152
-1% -$38K 1.42% 28
2014
Q3
$3.53M Buy
14,640
+31
+0.2% +$6.94K 1.37% 33
2014
Q2
$3.26M Sell
14,609
-18
-0.1% -$3.73K 1.23% 39
2014
Q1
$3.01M Sell
14,627
-13,503
-48% -$2.67M 1.2% 40
2013
Q4
$4.73M Buy
+28,130
New +$4.4M 1.89% 21

Other funds holding AGN

American National Bank & Trust's AGN Position: Q4 2018 in Review

American National Bank & Trust sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 5,530 shares — an estimated $1.05M sold.

American National Bank & Trust first reported a position in AGN in Q4 2013 and held it in 18 quarters. The position peaked at $4.73M in Q4 2013. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • American National Bank & Trust reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • American National Bank & Trust sold 5,530 Allergan plc shares in Q4 2018, an estimated $1.05M.
  • American National Bank & Trust first reported a position in Allergan plc in Q4 2013 and held it in 18 quarters.
  • American National Bank & Trust's Allergan plc position peaked at $4.73M in Q4 2013.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on American National Bank & Trust's 13F filing for Q4 2018, filed 11 Jan 2019.